These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34119273)

  • 1. The correlation of the serum level of L-carnitine with disease severity in patients with Amyotrophic lateral sclerosis.
    Sarraf P; Bitarafan S; Nafissi S; Fathi D; Abaj F; Asl Motallebnejad Z; Teimouri R; Vahedi K
    J Clin Neurosci; 2021 Jul; 89():232-236. PubMed ID: 34119273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
    Park Y; Park J; Kim Y; Baek H; Kim SH
    Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).
    WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 18 STUDY GROUP
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):40-48. PubMed ID: 28872915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients.
    Reich-Slotky R; Andrews J; Cheng B; Buchsbaum R; Levy D; Kaufmann P; Thompson JL
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):212-6. PubMed ID: 23452274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis.
    Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD
    Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress?
    Keizman D; Ish-Shalom M; Berliner S; Maimon N; Vered Y; Artamonov I; Tsehori J; Nefussy B; Drory VE
    J Neurol Sci; 2009 Oct; 285(1-2):95-9. PubMed ID: 19552925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
    Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
    JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.
    Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A
    Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysphagia in Amyotrophic Lateral Sclerosis: Relationships between disease progression and Fiberoptic Endoscopic Evaluation of Swallowing.
    Fattori B; Siciliano G; Mancini V; Bastiani L; Bongioanni P; Caldarazzo Ienco E; Barillari MR; Romeo SO; Nacci A
    Auris Nasus Larynx; 2017 Jun; 44(3):306-312. PubMed ID: 27569290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.
    Liu C; Jiang R; Yi X; Zhu W; Bu B
    J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials.
    Witzel S; Frauhammer F; Steinacker P; Devos D; Pradat PF; Meininger V; Halbgebauer S; Oeckl P; Schuster J; Anders S; Dorst J; Otto M; Ludolph AC
    Transl Neurodegener; 2021 Aug; 10(1):31. PubMed ID: 34433481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis.
    Henriques A; Blasco H; Fleury MC; Corcia P; Echaniz-Laguna A; Robelin L; Rudolf G; Lequeu T; Bergaentzle M; Gachet C; Pradat PF; Marchioni E; Andres CR; Tranchant C; Gonzalez De Aguilar JL; Loeffler JP
    PLoS One; 2015; 10(7):e0131512. PubMed ID: 26147510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis.
    Sugimoto K; Mori M; Liu J; Shibuya K; Isose S; Koide M; Hiwasa T; Kuwabara S
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):388-394. PubMed ID: 33792444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.
    Patin F; Corcia P; Madji Hounoum B; Veyrat-Durebex C; Respaud E; Piver E; Benz-de Bretagne I; Vourc'h P; Andres CR; Blasco H
    Eur J Neurol; 2015 Oct; 22(10):1385-90. PubMed ID: 26095828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of serum uric acid level with amyotrophic lateral sclerosis].
    Duan Y; Fan D
    Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(3):207-9. PubMed ID: 26879724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for peripheral immune activation in amyotrophic lateral sclerosis.
    Chen X; Feng W; Huang R; Guo X; Chen Y; Zheng Z; Shang H
    J Neurol Sci; 2014 Dec; 347(1-2):90-5. PubMed ID: 25312013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.